Patients’ perspectives on acromegaly diagnostic delay: a qualitative study

in European Journal of Endocrinology
Correspondence should be addressed to P Chanson; Email: philippe.chanson@bct.aphp.fr

*(J Sibeoni and E Manolios contributed equally to this work)

**(P Chanson and A Revah-Levy contributed equally to this work)

Restricted access

Context

Acromegaly has a substantial diagnostic delay associated with an increased risk of comorbidities and psychosocial deterioration. Qualitative methods which focus on the ways that individuals understand and relate to what they are experiencing are the best methods for exploring patients’ perspectives. To the best of our knowledge, they have not been developed in the context of acromegaly.

Objectives

This study aimed to explore the experience of the diagnostic pathway of patients with acromegaly.

Design

We conducted a qualitative study, based on 20 face-to-face unstructured interviews in a third referral Endocrinology center. Participants, purposively selected until data saturation, were patients with acromegaly with diverse disease durations, types of treatment or associated comorbidities. The data were examined by thematic analysis.

Results

Our analysis found four themes: (i) what happened for patients before the diagnosis; (ii) what happened after; (iii) the style or type of doctor involved and (iv) patients’ suggestions for limiting diagnostic delay. Our findings underlined the direct associations between diagnostic delay and the doctor–patient encounter, and the truly catastrophic experience of this disease, both before and after the diagnosis.

Conclusions

Diagnosis of acromegaly requires active medical involvement and awareness. Intervention of patient-experts in medical schools may help to be more aware of this disease. Endocrinologists caring for patients with acromegaly should also address the catastrophic dimension of the patient’s experience and initiate the narrative to help them to put it into words for preventing harmful consequences such as social isolation and QoL impairment, but also anxiety or depression.

 

     European Society of Endocrinology

Related Articles

Article Information

Metrics

All Time Past Year Past 30 Days
Abstract Views 748 748 90
Full Text Views 150 150 3
PDF Downloads 68 68 2

Altmetrics

References

  • 1

    ChansonPSalenaveSKamenickyP. Acromegaly. Handbook of Clinical Neurology 2014 124 197219. (https://doi.org/10.1016/B978-0-444-59602-4.00014-9)

  • 2

    MelmedS. Acromegaly pathogenesis and treatment. Journal of Clinical Investigation 2009 119 31893202. (https://doi.org/10.1172/JCI39375)

  • 3

    LavrentakiAPaluzziAWassJAKaravitakiN. Epidemiology of acromegaly: review of population studies. Pituitary 2017 20 49. (https://doi.org/10.1007/s11102-016-0754-x)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 4

    Ben-ShlomoASheppardMCStephensJMPulgarSMelmedS. Clinical, quality of life, and economic value of acromegaly disease control. Pituitary 2011 14 284294. (https://doi.org/10.1007/s11102-011-0310-7)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 5

    ColaoAFeroneDMarzulloPLombardiG. Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocrine Reviews 2004 25 102152. (https://doi.org/10.1210/er.2002-0022)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 6

    PetrossiansPDalyAFNatchevEMaioneLBlijdorpKSahnoun-FathallahMAuriemmaRDialloAMHultingALFeroneD Acromegaly at diagnosis in 3173 patients from the Liege Acromegaly Survey (LAS) database. Endocrine-Related Cancer 2017 24 505518. (https://doi.org/10.1530/ERC-17-0253)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7

    SiegelSStreetz-van der WerfCSchottJSNolteKKargesWKreitschmann-AndermahrI. Diagnostic delay is associated with psychosocial impairment in acromegaly. Pituitary 2013 16 507514. (https://doi.org/10.1007/s11102-012-0447-z)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 8

    AbreuATovarAPCastellanosRValenzuelaAGiraldoCMPinedoACGuerreroDPBarreraCAFrancoHIRibeiro-OliveiraAJr Challenges in the diagnosis and management of acromegaly: a focus on comorbidities. Pituitary 2016 19 448457. (https://doi.org/10.1007/s11102-016-0725-2)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 9

    ReidTJPostKDBruceJNNabi KanibirMReyes-VidalCMFredaPU. Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed. Clinical Endocrinology 2010 72 203208. (https://doi.org/10.1111/j.1365-2265.2009.03626.x)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10

    BrueTCastinettiF. The risks of overlooking the diagnosis of secreting pituitary adenomas. Orphanet Journal of Rare Diseases 2016 11 135. (https://doi.org/10.1186/s13023-016-0516-x)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 11

    KatznelsonLLawsERJrMelmedSMolitchMEMuradMHUtzAWassJA & Endocrine Society. Acromegaly: an endocrine society clinical practice guideline. Journal of Clinical Endocrinology and Metabolism 2014 99 39333951. (https://doi.org/10.1210/jc.2014-2700)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 12

    PrencipeNFlorianiIGuaraldiFDi GiacomoSVCannavoSArnaldiGBertonATorriVSpinelloMArvatE ACROSCORE: a new and simple tool for the diagnosis of acromegaly, a rare and underdiagnosed disease. Clinical Endocrinology 2016 84 380385. (https://doi.org/10.1111/cen.12959)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13

    KongXGongSSuLHowardNKongY. Automatic detection of acromegaly From facial photographs using machine learning methods. EBioMedicine 2018 27 94102. (https://doi.org/10.1016/j.ebiom.2017.12.015)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14

    MillerRELearned-MillerEGTrainerPPaisleyABlanzV. Early diagnosis of acromegaly: computers vs clinicians. Clinical Endocrinology 2011 75 226231. (https://doi.org/10.1111/j.1365-2265.2011.04020.x)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15

    BroderMSNearyMPChangECherepanovDKatznelsonL. Treatments, complications, and healthcare utilization associated with acromegaly: a study in two large United States databases. Pituitary 2014 17 333341. (https://doi.org/10.1007/s11102-013-0506-0)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16

    CaronPBrueTRaverotGTabarinACailleuxADelemerBRenoultPPHouchardAElarakiFChansonP. Signs and symptoms of acromegaly at diagnosis: the physician’s and the patient’s perspectives in the ACRO-POLIS study. Endocrine 2019 63 120129. (https://doi.org/10.1007/s12020-018-1764-4)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 17

    TruogRD. Patients and doctors – evolution of a relationship. New England Journal of Medicine 2012 366 581585. (https://doi.org/10.1056/NEJMp1110848)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 18

    DeshpandePRRajanSSudeepthiBLAbdul NazirCP. Patient-reported outcomes: a new era in clinical research. Perspectives in Clinical Research 2011 2 137144. (https://doi.org/10.4103/2229-3485.86879)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19

    Kreitschmann-AndermahrISiegelSKleistBKohlmannJStarzDBusleiRKoltowska-HaggstromMStrasburgerCJBuchfelderM. Diagnosis and management of acromegaly: the patient’s perspective. Pituitary 2016 19 268276. (https://doi.org/10.1007/s11102-015-0702-1)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 20

    MaysNPopeC. Qualitative research in health care. Assessing quality in qualitative research. BMJ 2000 320 5052. (https://doi.org/10.1136/bmj.320.7226.50)

  • 21

    SzczesniakDJawiarczyk-PrzybylowskaARymaszewskaJ. The quality of life and psychological, social and cognitive functioning of patients with acromegaly. Advances in Clinical and Experimental Medicine 2015 24 167172. (https://doi.org/10.17219/acem/38156)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 22

    OrriMSibeoniJBousquetGLabeyMGueguenJLaporteCWintermanSPicardCNascimbeniCVerneuilL Crossing the perspectives of patients, families, and physicians on cancer treatment: a qualitative study. Oncotarget 2017 8 2211322122. (https://doi.org/10.18632/oncotarget.12770)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 23

    BraunVClarkeVTerryG. Thematic analysis. In Qualitative Research in Clinical and Health Psychology. Eds RohlederP & LyonsA. Basingstoke, UK: Palgrave Macmillan2014.

    • Search Google Scholar
    • Export Citation
  • 24

    BraunVClarkeV. What can ‘thematic analysis’ offer health and wellbeing researchers? International Journal of Qualitative Studies on Health and Well-Being 2014 9 26152. (https://doi.org/10.3402/qhw.v9.26152)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 25

    TongASainsburyPCraigJ. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. International Journal for Quality in Health Care 2007 19 349357. (https://doi.org/10.1093/intqhc/mzm042)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 26

    ClemmonsDR. Consensus statement on the standardization and evaluation of growth hormone and insulin-like growth factor assays. Clinical Chemistry 2011 57 555559. (https://doi.org/10.1373/clinchem.2010.150631)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 27

    VilarLVilarCFLyraRLyraRNavesLA. Acromegaly: clinical features at diagnosis. Pituitary 2017 20 2232. (https://doi.org/10.1007/s11102-016-0772-8)

  • 28

    GurelMHBrueningPRRhodesCLomaxKG. Patient perspectives on the impact of acromegaly: results from individual and group interviews. Patient Prefer Adherence 2014 8 5362. (https://doi.org/10.2147/PPA.S56740)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 29

    NachtigallLDelgadoASwearingenBLeeHZeriklyRKlibanskiA. Changing patterns in diagnosis and therapy of acromegaly over two decades. Journal of Clinical Endocrinology and Metabolism 2008 93 20352041. (https://doi.org/10.1210/jc.2007-2149)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 30

    AgrawalMMaitinNRastogiKBhushanR. Seeing the unseen: diagnosing acromegaly in a dental setup. Case Reports 2013 2013 bcr2013200266. (https://doi.org/10.1136/bcr-2013-200266)

    • Search Google Scholar
    • Export Citation
  • 31

    DuncanCCacciatoreJ. A systematic review of the peer-reviewed literature on self-blame, guilt, and shame. Omega 2015 71 312342. (https://doi.org/10.1177/0030222815572604)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 32

    LimCBerryABLHirschTHartzlerALWagnerEHLudmanERalstonJD. ‘It just seems outside my health’: how patients with chronic conditions perceive communication boundaries with providers. DIS (Conference on Designing Interactive Systems) 2016 2016 11721184.

    • Search Google Scholar
    • Export Citation
  • 33

    AlpertJMDyerKELafataJE. Patient-centered communication in digital medical encounters. Patient Education and Counseling 2017 100 18521858. (https://doi.org/10.1016/j.pec.2017.04.019)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 34

    ZahariasG. Learning narrative-based medicine skills: narrative-based medicine 3. Canadian Family Physician Medecin de Famille Canadien 2018 64 352356.

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 35

    ElberseJECaron-FlintermanJFBroerseJE. Patient-expert partnerships in research: how to stimulate inclusion of patient perspectives. Health Expectations 2011 14 225239. (https://doi.org/10.1111/j.1369-7625.2010.00647.x)

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 36

    CrespoIValassiEWebbSM. Update on quality of life in patients with acromegaly. Pituitary 2017 20 185188. (https://doi.org/10.1007/s11102-016-0761-y)

  • 37

    SolomonEBranisteanuDDumbravaASolomonRGKissLGlodMPredaC. Executive functioning and quality of life in acromegaly. Psychology Research and Behavior Management 2019 12 3944. (https://doi.org/10.2147/PRBM.S183950)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 38

    AndelaCDNiemeijerNDScharlooMTiemensmaJKanagasabapathySPereiraAMKammingaNGKapteinAABiermaszNR. Towards a better quality of life (QoL) for patients with pituitary diseases: results from a focus group study exploring QoL. Pituitary 2015 18 86100. (https://doi.org/10.1007/s11102-014-0561-1)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 39

    WebbSMBadiaX. Quality of life in acromegaly. Neuroendocrinology 2016 103 106111. (https://doi.org/10.1159/000375451)

  • 40

    GeraedtsVJAndelaCDStallaGKPereiraAMvan FurthWRSieversCBiermaszNR. Predictors of quality of life in acromegaly: no consensus on biochemical parameters. Frontiers in Endocrinology 2017 8 40. (https://doi.org/10.3389/fendo.2017.00040)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 41

    GeraedtsVJDimopoulouCAuerMSchopohlJStallaGKSieversC. Health outcomes in acromegaly: depression and anxiety are promising targets for improving reduced quality of life. Frontiers in Endocrinology 2014 5 229. (https://doi.org/10.3389/fendo.2014.00229)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 42

    RoerinkSHWagenmakersMAWesselsJFSterenborgRBSmitJWHermusARNetea-MaierRT. Persistent self-consciousness about facial appearance, measured with the Derriford appearance scale 59, in patients after long-term biochemical remission of acromegaly. Pituitary 2015 18 366375. (https://doi.org/10.1007/s11102-014-0583-8)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 43

    ImranSATiemensmaJKaiserSMVallisMDoucetteSAbidiEYipCEDe TugwellBSiddiqiFClarkeDB. Morphometric changes correlate with poor psychological outcomes in patients with acromegaly. European Journal of Endocrinology 2016 174 4150. (https://doi.org/10.1530/EJE-15-0888)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 44

    DimopoulouCLeistnerSMIsingMSchneiderHJSchopohlJRutzSKosilekRFrohnerRStallaGKSieversC. Body image perception in acromegaly is not associated with objective acromegalic changes but depends on depressive symptoms. Neuroendocrinology 2017 105 115122. (https://doi.org/10.1159/000448519)

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 45

    SzczesniakDMJawiarczyk-PrzybylowskaAMatusiakŁBolanowskaAMaciaszekJSieminskaMRymaszewskaJBolanowskiM. Is there any difference in acromegaly and other chronic disease in quality of life and psychiatric morbidity? Endokrynologia Polska 2017 68 524532. (https://doi.org/10.5603/EP.a2017.0044)

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 46

    McCauslandKLWhiteMKGuthrieSDQuockTFinkelMLousadaIBaylissMS. Light chain (AL) amyloidosis: the journey to diagnosis. Patient 2018 11 207216.

Cited By

PubMed

Google Scholar